The DOI matches its Crossref record; 176 of the 176 references it cites were found in a registry or an index.
Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis
Open accessAbstract
Chronic kidney disease (CKD) represents a global health concern, and its prevalence is increasing. The ultimate therapeutic option for CKD is kidney transplantation. However, the use of drugs that target specific pathways to delay or halt CKD progression, such as angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and sodium-glucose co-transporter-2 (SGLT-2) inhibitors is limited in clinical practice. Mineralocorticoid receptor activation in nonclassical tissues, such as the endothelium, smooth muscle cells, inflammatory cells, podocytes, and fibroblasts may have deleterious effects on kidney structure and function. Several preclinical studies have shown that mineralocorticoid receptor antagonists (MRAs) ameliorate or cure kidney injury and dysfunction in different models of kidney disease. In this review, we present the preclinical evidence showing a benefit of MRAs in acute kidney injury, the transition from acute kidney injury to CKD, hypertensive and diabetic nephropathy, glomerulonephritis, and kidney toxicity induced by calcineurin inhibitors. We also discuss the molecular mechanisms responsible for renoprotection related to MRAs that lead to reduced oxidative stress, inflammation, fibrosis, and hemodynamic alterations. The available clinical data support a benefit of MRA in reducing proteinuria in diabetic kidney disease and improving cardiovascular outcomes in CKD patients. Moreover, a benefit of MRAs in kidney transplantation has also been observed. The past and present clinical trials describing the effect of MRAs on kidney injury are presented, and the risk of hyperkalemia and use of other options, such as potassium binding agents or nonsteroidal MRAs, are also addressed. Altogether, the available preclinical and clinical data support a benefit of using MRAs in CKD, an approach that should be further explored in future clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
Bakris, G. L., Agarwal, R., Chan, J. C., Cooper, M. E., Gansevoort, R. T., Haller, H., Remuzzi, G., Rossing, P., Schmieder, R. E., Nowack, C., et al. (2015) · JAMA · doi:10.1001/jama.2015.10081 · Cited by 708
Brilla, C. G., Zhou, G., Matsubara, L., & Weber, K. T. (1994) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1994.1098 · Cited by 694
Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS Inhibitors
Weir, M. R., Bakris, G. L., Bushinsky, D. A., Mayo, M. R., Garza, D., Stasiv, Y., Wittes, J., Christ-Schmidt, H., Berman, L., & Pitt, B. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1410853 · Cited by 669
Maggioni, A. P., Anker, S. D., Dahlström, U., Filippatos, G., Ponikowski, P., Zannad, F., Amir, O., Chioncel, O., Leiro, M. C., Drozdz, J., et al. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft134 · Cited by 667
Levey, A. S., Inker, L. A., Matsushita, K., Greene, T., Willis, K., Lewis, E., de Zeeuw, D., Cheung, A. K., & Coresh, J. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.07.030 · Cited by 620
Pitt, B., Kober, L., Ponikowski, P., Gheorghiade, M., Filippatos, G., Krum, H., Nowack, C., Kolkhof, P., Kim, S.-Y., & Zannad, F. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht187 · Cited by 591
Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats
Blasi, E. R., Rocha, R., Rudolph, A. E., Blomme, E. A. G., Polly, M. L., & McMahon, E. G. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00929.x · Cited by 542
Sodium Zirconium Cyclosilicate in Hyperkalemia
Packham, D. K., Rasmussen, H. S., Lavin, P. T., El-Shahawy, M. A., Roger, S. D., Block, G., Qunibi, W., Pergola, P., & Singh, B. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411487 · Cited by 506
Role of aldosterone in the remnant kidney model in the rat.
Greene, E. L., Kren, S., & Hostetter, T. H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118867 · Cited by 479
Effectiveness of Aldosterone Blockade in Patients With Diabetic Nephropathy
Sato, A., Hayashi, K., Naruse, M., & Saruta, T. (2003) · Hypertension · doi:10.1161/01.hyp.0000044937.95080.e9 · Cited by 466
Shibata, S., Nagase, M., Yoshida, S., Kawarazaki, W., Kurihara, H., Tanaka, H., Miyoshi, J., Takai, Y., & Fujita, T. (2008) · Nature Medicine · doi:10.1038/nm.1879 · Cited by 459
Kolkhof, P., Delbeck, M., Kretschmer, A., Steinke, W., Hartmann, E., Bärfacker, L., Eitner, F., Albrecht-Küpper, B., & Schäfer, S. (2014) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000091 · Cited by 430
The incidence and implications of aldosterone breakthrough
Bomback, A. S., & Klemmer, P. J. (2007) · Nature Clinical Practice Nephrology · doi:10.1038/ncpneph0575 · Cited by 420
Kosiborod, M., Rasmussen, H. S., Lavin, P., Qunibi, W. Y., Spinowitz, B., Packham, D., Roger, S. D., Yang, A., Lerma, E., & Singh, B. (2014) · JAMA · doi:10.1001/jama.2014.15688 · Cited by 415
Usher, M. G., Duan, S. Z., Ivaschenko, C. Y., Frieler, R. A., Berger, S., Schütz, G., Lumeng, C. N., & Mortensen, R. M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41080 · Cited by 383
Podocyte as the Target for Aldosterone: Roles of Oxidative Stress and Sgk1
Shibata, S., Nagase, M., Yoshida, S., Kawachi, H., & Fujita, T. (2007) · Hypertension · doi:10.1161/01.hyp.0000255636.11931.a2 · Cited by 362
Galectin-3 Mediates Aldosterone-Induced Vascular Fibrosis
Calvier, L., Miana, M., Reboul, P., Cachofeiro, V., Martinez-Martinez, E., de Boer, R. A., Poirier, F., Lacolley, P., Zannad, F., Rossignol, P., et al. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.300569 · Cited by 359
Jaffe, I. Z., & Mendelsohn, M. E. (2005) · Circulation Research · doi:10.1161/01.res.0000159937.05502.d1 · Cited by 358
Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors
McCurley, A., Pires, P. W., Bender, S. B., Aronovitz, M., Zhao, M. J., Metzger, D., Chambon, P., Hill, M. A., Dorrance, A. M., Mendelsohn, M. E., et al. (2012) · Nature Medicine · doi:10.1038/nm.2891 · Cited by 347
Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity
Leopold, J. A., Dam, A., Maron, B. A., Scribner, A. W., Liao, R., Handy, D. E., Stanton, R. C., Pitt, B., & Loscalzo, J. (2007) · Nature Medicine · doi:10.1038/nm1545 · Cited by 346
The Number, Quality, and Coverage of Randomized Controlled Trials in Nephrology
Strippoli, G. F. M., Craig, J. C., & Schena, F. P. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000100125.21491.46 · Cited by 343
Bianchi, S., Bigazzi, R., & Campese, V. M. (2006) · Kidney International · doi:10.1038/sj.ki.5001854 · Cited by 338
Jaisser, F., & Farman, N. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011106 · Cited by 327
Self-citationNishiyama, A., Yao, L., Nagai, Y., Miyata, K., Yoshizumi, M., Kagami, S., Kondo, S., Kiyomoto, H., Shokoji, T., Kimura, S., et al. (2004) · Hypertension · doi:10.1161/01.hyp.0000118519.66430.22 · Cited by 314
Role of Aldosterone in Renal Vascular Injury in Stroke-Prone Hypertensive Rats
Rocha, R., Chander, P. N., Zuckerman, A., & Stier, C. T. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.232 · Cited by 310
Rickard, A. J., Morgan, J., Tesch, G., Funder, J. W., Fuller, P. J., & Young, M. J. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.131110 · Cited by 303
Levey, A. S., Cattran, D., Friedman, A., Miller, W. G., Sedor, J., Tuttle, K., Kasiske, B., & Hostetter, T. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.04.029 · Cited by 298
Edwards, N. C., Steeds, R. P., Stewart, P. M., Ferro, C. J., & Townend, J. N. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.03.066 · Cited by 286
Caprio, M., Newfell, B. G., la Sala, A., Baur, W., Fabbri, A., Rosano, G., Mendelsohn, M. E., & Jaffe, I. Z. (2008) · Circulation Research · doi:10.1161/circresaha.108.174235 · Cited by 285
Kolkhof, P., & Bärfacker, L. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0600 · Cited by 262
Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo
Brown, N. J., Nakamura, S., Ma, L., Nakamura, I., Donnert, E., Freeman, M., Vaughan, D. E., & Fogo, A. B. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00277.x · Cited by 255
Schjoedt, K. J., Andersen, S., Rossing, P., Tarnow, L., & Parving, H.-H. (2004) · Diabetologia · doi:10.1007/s00125-004-1542-0 · Cited by 249
Nagase, M., Shibata, S., Yoshida, S., Nagase, T., Gotoda, T., & Fujita, T. (2006) · Hypertension · doi:10.1161/01.hyp.0000222003.28517.99 · Cited by 248
Eschalier, R., McMurray, J. J. V., Swedberg, K., van Veldhuisen, D. J., Krum, H., Pocock, S. J., Shi, H., Vincent, J., Rossignol, P., Zannad, F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.04.086 · Cited by 247
Aldosterone Activates Vascular p38MAP Kinase and NADPH Oxidase Via c-Src
Callera, G. E., Touyz, R. M., Tostes, R. C., Yogi, A., He, Y., Malkinson, S., & Schiffrin, E. L. (2005) · Hypertension · doi:10.1161/01.hyp.0000154365.30593.d3 · Cited by 246
Keidar, S., Kaplan, M., Pavlotzky, E., Coleman, R., Hayek, T., Hamoud, S., & Aviram, M. (2004) · Circulation · doi:10.1161/01.cir.0000127949.05756.9d · Cited by 244
Drug-Induced Reduction in Albuminuria Is Associated with Subsequent Renoprotection: A Meta-Analysis
Lambers Heerspink, H. J., Kröpelin, T. F., Hoekman, J., & de Zeeuw, D. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014070688 · Cited by 242
Amador, C. A., Barrientos, V., Peña, J., Herrada, A. A., González, M., Valdés, S., Carrasco, L., Alzamora, R., Figueroa, F., Kalergis, A. M., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02883 · Cited by 226
Glucocorticoids exert opposing effects on macrophage function dependent on their concentration
Lim, H., Müller, N., Herold, M. J., Van Den Brandt, J., & Reichardt, H. M. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02611.x · Cited by 218
The Impact of Galectin-3 Inhibition on Aldosterone-Induced Cardiac and Renal Injuries
Calvier, L., Martinez-Martinez, E., Miana, M., Cachofeiro, V., Rousseau, E., Sádaba, J. R., Zannad, F., Rossignol, P., & López-Andrés, N. (2015) · JACC: Heart Failure · doi:10.1016/j.jchf.2014.08.002 · Cited by 215
Currie, G., Taylor, A. H. M., Fujita, T., Ohtsu, H., Lindhardt, M., Rossing, P., Boesby, L., Edwards, N. C., Ferro, C. J., Townend, J. N., et al. (2016) · BMC Nephrology · doi:10.1186/s12882-016-0337-0 · Cited by 214
Miyata, K., Rahman, M., Shokoji, T., Nagai, Y., Zhang, G.-X., Sun, G.-P., Kimura, S., Yukimura, T., Kiyomoto, H., Kohno, M., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005040390 · Cited by 212
Maron, B. A., Zhang, Y.-Y., White, K., Chan, S. Y., Handy, D. E., Mahoney, C. E., Loscalzo, J., & Leopold, J. A. (2012) · Circulation · doi:10.1161/circulationaha.112.094722 · Cited by 200
Trevisan, M., de Deco, P., Xu, H., Evans, M., Lindholm, B., Bellocco, R., Barany, P., Jernberg, T., Lund, L. H., & Carrero, J. J. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1199 · Cited by 194
Aldosterone Promotes Autoimmune Damage by Enhancing Th17-Mediated Immunity
Herrada, A. A., Contreras, F. J., Marini, N. P., Amador, C. A., González, P. A., Cortés, C. M., Riedel, C. A., Carvajal, C. A., Figueroa, F., Michea, L. F., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0802886 · Cited by 191
Kolkhof, P., Jaisser, F., Kim, S.-Y., Filippatos, G., Nowack, C., & Pitt, B. (2016) · Handbook of Experimental Pharmacology · doi:10.1007/164_2016_76 · Cited by 180
Self-citationSpironolactone prevents early renal injury in streptozotocin-induced diabetic rats
Fujisawa, G., Okada, K., Muto, S., Fujita, N., Itabashi, N., Kusano, E., & Ishibashi, S. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00913.x · Cited by 179
Zannad, F., Gattis Stough, W., Rossignol, P., Bauersachs, J., McMurray, J. J. V., Swedberg, K., Struthers, A. D., Voors, A. A., Ruilope, L. M., Bakris, G. L., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs257 · Cited by 178
Guo, C., Martinez-Vasquez, D., Mendez, G. P., Toniolo, M. F., Yao, T. M., Oestreicher, E. M., Kikuchi, T., Lapointe, N., Pojoga, L., Williams, G. H., et al. (2006) · Endocrinology · doi:10.1210/en.2006-0944 · Cited by 173
Han, S.-Y., Kim, C.-H., Kim, H.-S., Jee, Y.-H., Song, H.-K., Lee, M.-H., Han, K.-H., Kim, H.-K., Kang, Y.-S., Han, J.-Y., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005111196 · Cited by 172
Endothelial Mineralocorticoid Receptor Mediates Diet-Induced Aortic Stiffness in Females
Jia, G., Habibi, J., Aroor, A. R., Martinez-Lemus, L. A., DeMarco, V. G., Ramirez-Perez, F. I., Sun, Z., Hayden, M. R., Meininger, G. A., Mueller, K. B., et al. (2016) · Circulation Research · doi:10.1161/circresaha.115.308269 · Cited by 172
Regression of Existing Glomerulosclerosis by Inhibition of Aldosterone
Aldigier, J. C., Kanjanbuch, T., Ma, L.-J., Brown, N. J., & Fogo, A. B. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004090804 · Cited by 171
Local Angiotensin II and Transforming Growth Factor-β1 in Renal Fibrosis of Rats
Sun, Y., Zhang, J., Zhang, J. Q., & Ramires, F. J. A. (2000) · Hypertension · doi:10.1161/01.hyp.35.5.1078 · Cited by 166
Aldosterone antagonists for preventing the progression of chronic kidney disease
Navaneethan, S. D., Nigwekar, S. U., & Strippoli, G. F. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007004 · Cited by 166
Bakris, G., Burgess, E., Weir, M., Davidai, G., & Koval, S. (2008) · Kidney International · doi:10.1038/ki.2008.204 · Cited by 162
The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure
Cat, A. N. D., Griol‐Charhbili, V., Loufrani, L., Labat, C., Benjamin, L., Farman, N., Lacolley, P., Henrion, D., & Jaisser, F. (2010) · The FASEB Journal · doi:10.1096/fj.09-147926 · Cited by 161
Self-citationZhou, G., Kandala, J. C., Tyagi, S. C., Katwa, L. C., & Weber, K. T. (1996) · Molecular and Cellular Biochemistry · doi:10.1007/bf00226785 · Cited by 158
Nagai, Y., Miyata, K., Sun, G.-P., Rahman, M., Kimura, S., Miyatake, A., Kiyomoto, H., Kohno, M., Abe, Y., Yoshizumi, M., et al. (2005) · Hypertension · doi:10.1161/01.hyp.0000174593.88899.68 · Cited by 158
Kang, Y., Zhang, Z.-H., Johnson, R. F., Yu, Y., Beltz, T. G., Johnson, A. K., Weiss, R. M., & Felder, R. B. (2006) · Circulation Research · doi:10.1161/01.res.0000244092.95152.86 · Cited by 157
Nagase, M., Matsui, H., Shibata, S., Gotoda, T., & Fujita, T. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.091058 · Cited by 157
Nishiyama, A., Yao, L., Fan, Y.-Y., Kyaw, M. H., Kataoka, N., Hashimoto, K., Nagai, Y., Nakamura, E., Yoshizumi, M., Shokoji, T., et al. (2005) · Hypertension · doi:10.1161/01.hyp.0000154681.38944.9a · Cited by 152
Therapeutic benefit of spironolactone in experimental chronic cyclosporine A nephrotoxicity
Feria, I. G., Pichardo, I., Juárez, P., Ramírez, V., González, M. A., Uribe, N., García-Torres, R., López‐Casillas, F., Gamba, G., & Bobadilla, N. A. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00707.x · Cited by 150
Gilmour, J. S., Coutinho, A. E., Cailhier, J., Man, T. Y., Clay, M., Thomas, G. D., Harris, H. J., Mullins, J. J., Seckl, J. R., Savill, J., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7605 · Cited by 148
Lattenist, L., Lechner, S. M., Messaoudi, S., Mercier, A. L., Moghrabi, S. E., Prince, S., Bobadilla, N. A., Kolkhof, P., Jaisser, F., & Barrera‐Chimal, J. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08526 · Cited by 146
Self-citationMejia-Vilet, J. M., Ramírez, V., Cruz, C., Uribe, N., Gamba, G., & Bobadilla, N. A. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00077.2007 · Cited by 144
T-Cell Mineralocorticoid Receptor Controls Blood Pressure by Regulating Interferon-Gamma
Sun, X.-N., Li, C., Liu, Y., Du, L., Zeng, M., Zheng, X., Zhang, W.-C., Liu, Y., Zhu, M., Kong, D., et al. (2017) · Circulation Research · doi:10.1161/circresaha.116.310480 · Cited by 143
Quinkler, M. O., Zehnder, D., Eardley, K. S., Lepenies, J., Howie, A. J., Hughes, S. V., Cockwell, P., Hewison, M., & Stewart, P. M. (2005) · Circulation · doi:10.1161/circulationaha.105.539122 · Cited by 137
Pruthi, D., McCurley, A., Aronovitz, M. A., Galayda, C., Karumanchi, S. A., & Jaffe, I. Z. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.302854 · Cited by 137
Aldosterone Induces Superoxide Generation via Rac1 Activation in Endothelial Cells
Iwashima, F., Yoshimoto, T., Minami, I., Sakurada, M., Hirono, Y., & Hirata, Y. (2007) · Endocrinology · doi:10.1210/en.2007-0864 · Cited by 134
New insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone
Bobadilla, N. A., & Gamba, G. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00072.2007 · Cited by 132
Nonsteroidal antagonists of the mineralocorticoid receptor
Kolkhof, P., Nowack, C., & Eitner, F. (2015) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000147 · Cited by 129
Sarwar, C. M. S., Papadimitriou, L., Pitt, B., Piña, I. L., Zannad, F. M., Anker, S. D., Gheorghiade, M., & Butler, J. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.06.060 · Cited by 127
Acute Kidney Injury to Chronic Kidney Disease Transition
Fiorentino, M., Grandaliano, G., Gesualdo, L., & Castellano, G. (2018) · Contributions to nephrology · doi:10.1159/000484962 · Cited by 127
Ackermann, D., Gresko, N., Carrel, M., Loffing‐Cueni, D., Habermehl, D., Gómez-Sánchez, C. E., Rossier, B. C., & Loffing, J. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00437.2010 · Cited by 126
Martín‐Fernández, B., Rubio‐Navarro, A., Cortegano, I., Ballesteros, S., Alía, M., Cannata‐Ortiz, P., Olivares-Álvaro, E., Egido, J., de Andrés, B., Gaspar, M.-L., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0145946 · Cited by 125
Galmiche, G., Pizard, A., Gueret, A., Moghrabi, S. E., Ouvrard‐Pascaud, A., Berger, S., Challande, P., Jaffe, I. Z., Labat, C., Lacolley, P. J., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01967 · Cited by 124
Self-citationCalò, L. A., Zaghetto, F., Pagnin, E., Davis, P. A., de Mozzi, P., Sartorato, P., Martire, G., Fiore, C., & Armanini, D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031545 · Cited by 122
Spironolactone prevents chronic kidney disease caused by ischemic acute kidney injury
Barrera‐Chimal, J., Pérez‐Villalva, R., Rodríguez‐Romo, R., Reyna, J. C. G., Uribe, N., Gamba, G., & Bobadilla, N. A. (2012) · Kidney International · doi:10.1038/ki.2012.352 · Cited by 122
Self-citationAldosterone Stimulates Epidermal Growth Factor Receptor Expression
Krug, A. W., Großmann, C., Schuster, C., Freudinger, R., Mildenberger, S., Govindan, M. V., & Gekle, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308134200 · Cited by 122
Krug, A. W., Allenhöfer, L., Monticone, R. E., Spinetti, G., Gekle, M., Wang, M., & Lakatta, E. G. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.148783 · Cited by 117
Frieler, R. A., Meng, H., Duan, S. Z., Berger, S., Schütz, G., He, Y., Xi, G., Wang, M. M., & Mortensen, R. M. (2010) · Stroke · doi:10.1161/strokeaha.110.598441 · Cited by 116
Pérez‐Rojas, J. M., Blanco, J. A., Cruz, C., Trujillo, J., Vaidya, V. S., Uribe, N., Bonventre, J. V., Gamba, G., & Bobadilla, N. A. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00147.2006 · Cited by 112
Charytan, D. M., Himmelfarb, J., Ikizler, T. A., Raj, D. S., Hsu, J. Y., Landis, J. R., Anderson, A. H., Hung, A. M., Mehrotra, R., Sharma, S., et al. (2018) · Kidney International · doi:10.1016/j.kint.2018.08.034 · Cited by 112
Takebayashi, K., Matsumoto, S., Aso, Y., & Inukai, T. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1718 · Cited by 110
DuPont, J. J., & Jaffe, I. Z. (2017) · Journal of Endocrinology · doi:10.1530/joe-17-0009 · Cited by 110
Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence
MIN, L., MOGI, M., IWANAMI, J., LI, J., SAKATA, A., FUJITA, T., TSUKUDA, K., IWAI, M., & HORIUCHI, M. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.07.008 · Cited by 105
Tarjus, A., Martínez‐Martínez, E., Amador, C. A., Latouche, C., Moghrabi, S. E., Berger, T., Mak, T. W., Fay, R., Farman, N., Rossignol, P., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05431 · Cited by 105
Self-citationQuach, K., Lvtvyn, L., Baigent, C., Bueti, J., Garg, A. X., Hawley, C. M., Haynes, R., Manns, B., Perkovic, V., Rabbat, C. G., et al. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.04.011 · Cited by 105
Hammer, F., Malzahn, U., Donhauser, J., Betz, C., Schneider, M. P., Grupp, C., Pollak, N., Störk, S., Wanner, C., Krane, V., et al. (2019) · Kidney International · doi:10.1016/j.kint.2018.11.025 · Cited by 96
Benefit of Mineralocorticoid Receptor Antagonism in AKI: Role of Vascular Smooth Muscle Rac1
Barrera‐Chimal, J., André‐Grégoire, G., Cat, A. N. D., Lechner, S. M., Cau, J., Prince, S., Kolkhof, P., Loirand, G., Sauzeau, V., Hauet, T., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016040477 · Cited by 95
Self-citationTaira, M., Toba, H., Murakami, M., Iga, I., Serizawa, R., Murata, S., Kobara, M., & Nakata, T. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.06.019 · Cited by 93
Vukadinović, D., Lavall, D., Vukadinović, A. N., Pitt, B., Wagenpfeil, S., & Böhm, M. (2017) · American Heart Journal · doi:10.1016/j.ahj.2017.03.011 · Cited by 92
Martínez‐Martínez, E., Buonafine, M., Boukhalfa, I., Ibarrola, J., Fernández‐Celis, A., Kolkhof, P., Rossignol, P., Girerd, N., Mulder, P. G. H., López‐Andrés, N., et al. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.09791 · Cited by 92
Self-citationLiu, L. C. Y., Schutte, E., Gansevoort, R. T., van der Meer, P., & Voors, A. A. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.1059819 · Cited by 91
Arai, K., Tsuruoka, H., & Homma, T. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.11.028 · Cited by 87
Bamberg, K., Johansson, U., Edman, K., William‐Olsson, L., Myhre, S., Gunnarsson, A., Geschwindner, S., Aagaard, A., Granqvist, A., Jaisser, F., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193380 · Cited by 85
Self-citationPitt, B., & Bakris, G. L. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.04889 · Cited by 81
Bostick, B., Habibi, J., DeMarco, V. G., Jia, G., Domeier, T. L., Lambert, M. D., Aroor, A. R., Nistala, R., Bender, S. B., Garro, M., et al. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00898.2014 · Cited by 80
Revisiting RAAS blockade in CKD with newer potassium-binding drugs
Georgianos, P. I., & Agarwal, R. (2017) · Kidney International · doi:10.1016/j.kint.2017.08.038 · Cited by 79
Spironolactone in chronic hemodialysis patients improves cardiac function.
Taheri, S., Mortazavi, M., Shahidi, S., Pourmoghadas, A., Garakyaraghi, M., Seirafian, S., Eshaghian, A., & Ghassami, M. (2009) · PubMed · Cited by 77
Mineralocorticoid receptor‐mediated DNA damage in kidneys of DOCA‐salt hypertensive rats
Schupp, N., Kolkhof, P., Queisser, N., Gärtner, S., Schmid, U., Kretschmer, A., Hartmann, E., Oli, R. G., Schäfer, S., & Stopper, H. (2010) · The FASEB Journal · doi:10.1096/fj.10-173286 · Cited by 76
Hou, J. Y., Xiong, W., Cao, L., Wen, X., & Li, A. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.05.508 · Cited by 71
Recovery from ischemic acute kidney injury by spironolactone administration
Sanchez-Pozos, K. A., Barrera‐Chimal, J., Garzon-Muvdi, J., Pérez‐Villalva, R., Rodríguez‐Romo, R., Cruz, C., Gamba, G., & Bobadilla, N. A. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs014 · Cited by 71
Self-citationSun, J., Li, C., Shen, Z., Zhang, W., Ai, T.-J., Du, L., Zhang, Y., Yao, G.-F., Liu, Y., Sun, S., et al. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.307031 · Cited by 70
Taheri, S., Mortazavi, M., Pourmoghadas, A., et al. (2012) · PubMed · doi:10.4103/1319-2442.95778 · Cited by 69
Edwards, N. C., Ferro, C. J., Kirkwood, H., Chue, C. D., Young, A. A., Stewart, P. M., Steeds, R. P., & Townend, J. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.07.018 · Cited by 68
Diabetic nephropathy: newer therapeutic perspectives
Keri, K., Samji, N. S., & Blumenthal, S. S. (2018) · Journal of Community Hospital Internal Medicine Perspectives · doi:10.1080/20009666.2018.1500423 · Cited by 68
Myeloid Mineralocorticoid Receptor Activation Contributes to Progressive Kidney Disease
Huang, L., Nikolic‐Paterson, D. J., Han, Y., Ozols, E., Ma, F. Y., Young, M. J., & Tesch, G. H. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012111094 · Cited by 67
Zhou, X., Ono, H., Ono, Y., & Frohlich, E. D. (2004) · American Journal of Nephrology · doi:10.1159/000077396 · Cited by 66
Shen, J., Morgan, J., Tesch, G. H., Rickard, A. J., Chrissobolis, S., Drummond, G. R., Fuller, P. J., & Young, M. J. (2016) · Endocrinology · doi:10.1210/en.2016-1040 · Cited by 66
Barrera‐Chimal, J., Prince, S., Fadel, F., Moghrabi, S. E., Warnock, D. G., Kolkhof, P., & Jaisser, F. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014121216 · Cited by 65
Self-citationSpironolactone suppresses inflammation and prevents L-NAME–induced renal injury in rats
Ikeda, H., Tsuruya, K., Toyonaga, J., Masutani, K., Hayashida, H., Hirakata, H., & Iida, M. (2008) · Kidney International · doi:10.1038/ki.2008.507 · Cited by 65
Pretorius, M., Murray, K. T., Yu, C., Byrne, J. G., Billings, F. T., Petracek, M. R., Greelish, J. P., Hoff, S. J., Ball, S. K., Mishra, V. K., et al. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e31825b8be2 · Cited by 65
Buonafine, M., Martínez‐Martínez, E., Amador, C. A., Gravez, B., Ibarrola, J., Fernández‐Celis, A., Moghrabi, S. E., Rossignol, P., López‐Andrés, N., & Jaisser, F. (2017) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2017.12.011 · Cited by 63
Self-citationThe Mineralocorticoid Receptor and Oxidative Stress
Fiebeler, A., & Luft, F. C. (2005) · Heart Failure Reviews · doi:10.1007/s10741-005-2348-y · Cited by 62
Esteghamati, A., Noshad, S., Jarrah, S., Mousavizadeh, M., Khoee, S. H., & Nakhjavani, M. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft281 · Cited by 62
Kang, Y. S., Ko, G.-J., Lee, M. H., Song, H. K., Han, S. Y., Han, K. H., Kim, H. K., Han, J., & Cha, D. R. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn448 · Cited by 62
Oxidative stress in patients affected by primary aldosteronism
Petramala, L., Pignatelli, P., Carnevale, R., Zinnamosca, L., Marinelli, C., Settevendemmie, A., Concistrè, A., Tonnarini, G., Toma, G. D., Violi, F., et al. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000284 · Cited by 62
Arai, K., Morikawa, Y., Ubukata, N., Tsuruoka, H., & Homma, T. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.234765 · Cited by 62
Cole, T. J., & Young, M. J. (2017) · Journal of Endocrinology · doi:10.1530/joe-17-0155 · Cited by 62
The Role of Mineralocorticoid Receptor Expression in Brain Remodeling after Cerebral Ischemia
Oyamada, N., Sone, M., Miyashita, K., Park, K., Taura, D., Inuzuka, M., Sonoyama, T., Tsujimoto, H., Fukunaga, Y., Tamura, N., et al. (2008) · Endocrinology · doi:10.1210/en.2007-1770 · Cited by 58
Pitt, B., Bakris, G. L., Weir, M. R., Freeman, M. W., Lainščak, M., Mayo, M. R., Garza, D., Zawadzki, R., Berman, L., & Bushinsky, D. A. (2018) · ESC Heart Failure · doi:10.1002/ehf2.12292 · Cited by 57
Lother, A., Fürst, D., Bergemann, S., Gilsbach, R., Grahammer, F., Huber, T. B., Hilgendorf, I., Bode, C., Moser, M., & Hein, L. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.06530 · Cited by 55
Orena, S., Maurer, T. S., She, L., Eudy, R. J., Bernardo, V., Dash, D., Loria, P. M., Banker, M. E., Tugnait, M., Okerberg, C. V., et al. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00115 · Cited by 54
Lachaux, M., Barrera‐Chimal, J., Nicol, L., Rémy‐Jouet, I., Renet, S., Dumesnil, A., Wecker, D., Richard, V. J., Kolkhof, P., Jaisser, F., et al. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13393 · Cited by 54
Self-citationLi, C., Zhang, Y. Y., Frieler, R. A., Xiao, Z., Zhang, W. C., Sun, X., Yang, Q. Z., Min, S., Huang, B., Berger, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110950 · Cited by 51
Ojeda‐Cervantes, M., Barrera‐Chimal, J., Alberú, J., Pérez‐Villalva, R., Morales-Buenrostro, L. E., & Bobadilla, N. A. (2013) · American Journal of Nephrology · doi:10.1159/000350539 · Cited by 50
Self-citationLeft ventricular dysfunction in the haemodialysis population
Sood, M. M., Pauly, R. P., Rigatto, C., & Komenda, P. V. J. (2008) · Clinical Kidney Journal · doi:10.1093/ndtplus/sfn074 · Cited by 50
Aldosterone induces mesangial cell apoptosis both in vivo and in vitro
Mathew, J. T., Patni, H., Chaudhary, A. N., Liang, W., Gupta, A., Chander, P. N., Ding, G., & Singhal, P. C. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00435.2007 · Cited by 50
Boesby, L., Elung‐Jensen, T., Klausen, T. W., Strandgaard, S., & Kamper, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026904 · Cited by 49
Chen, D., Chen, Z., Park, C., McCarthy, T. L., Chen, L., Alomari, A. K., & Moeckel, G. W. (2013) · Gene · doi:10.1016/j.gene.2013.08.047 · Cited by 48
Armanini, D., Endres, S., Kuhnle, U., & Weber, P. C. (1988) · European Journal of Endocrinology · doi:10.1530/acta.0.1180479 · Cited by 48
Lano, F. A. D., & Schmid‐Schönbein, G. W. (2004) · Microcirculation · doi:10.1080/10739680490266207 · Cited by 47
Nishiyama, A., Kobori, H., Konishi, Y., Morikawa, T., Maeda, I., Okumura, M., Kishida, M., Hamada, M., Nagai, Y., Nakagawa, T., et al. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.158113 · Cited by 47
Barba-Navarro, R., Tapia-Silva, M., Garza-García, C. A., López-Giacoman, S. R., Melgoza-Toral, I. E., Vázquez-Rangel, A., Bazúa‐Valenti, S., Bobadilla, N. A., de Lay, M. W., Baranda, F., et al. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.06.013 · Cited by 47
Diah, S., Zhang, G., Nagai, Y., Zhang, W., Liu, G., Kimura, S., Hamid, M. R. W. H. A., Tamiya, T., Nishiyama, A., & Hitomi, H. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.09.018 · Cited by 46
Irita, J., Okura, T., Manabe, S., Kurata, M., MIYOSHI, K., Watanabe, S., FUKUOKA, T., & Higaki, J. (2006) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.08.019 · Cited by 46
Chen, H., Sun, F., Zhong, X., Shao, Y., Yoshimura, A., & Liu, Y. (2013) · Kidney & Blood Pressure Research · doi:10.1159/000355736 · Cited by 46
Yoshida, S., Ishizawa, K., Ayuzawa, N., Ueda, K., Takeuchi, M., Kawarazaki, W., Fujita, T., & Nagase, M. (2014) · Nephron Experimental Nephrology · doi:10.1159/000358758 · Cited by 45
Mineralocorticoid and SGK1-Sensitive Inflammation and Tissue Fibrosis
Artunç, F., & Lang, F. J. W. (2014) · Nephron Physiology · doi:10.1159/000368267 · Cited by 45
Pessôa, B. S., Peixoto, E. B. M. I., Papadimitriou, A., de Faria, J. M. L., & de Faria, J. B. L. (2011) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320311422581 · Cited by 45
Management of hyperkalaemia consequent to mineralocorticoid-receptor antagonist therapy
Roscioni, S. S., de Zeeuw, D., Bakker, S. J. L., & Heerspink, H. J. L. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.217 · Cited by 44
Irita, J., Okura, T., Kurata, M., Miyoshi, K., Fukuoka, T., & Higaki, J. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.102640 · Cited by 44
Bonnard, B., Pieronne-Deperrois, M., Djerada, Z., Moghrabi, S. E., Kolkhof, P., Ouvrard‐Pascaud, A., Mulder, P. G. H., Jaisser, F., & Messaoudi, S. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.06.008 · Cited by 43
Self-citationRole of mineralocorticoid receptor/Rho/Rho-kinase pathway in obesity-related renal injury
Tokuyama, H., Wakino, S., Hara, Y., Washida, N., Fujimura, K., Hosoya, K., Yoshioka, K., Hasegawa, K., Minakuchi, H., Homma, K., et al. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.232 · Cited by 42
Boesby, L., Elung‐Jensen, T., Strandgaard, S., & Kamper, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064549 · Cited by 39
Cardiac macrophages and apoptosis after myocardial infarction: effects of central MR blockade
Rafatian, N., Westcott, K. V., White, R. A., & Leenen, F. H. H. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00075.2014 · Cited by 39
Moranne, O., Bakris, G., Fafin, C., Favre, G., Pradier, C., & Esnault, V. (2013) · American Society of Nephrology. Clinical Journal · doi:10.2215/cjn.06960712 · Cited by 39
Girerd, N., Ferreira, J. P., Rossignol, P., & Zannad, F. M. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.621 · Cited by 37
Hill, N. R., Lasserson, D. S., Thompson, B. A. V., Perera, R., Wolstenholme, J. L., Bower, P., Blakeman, T., Fitzmaurice, D. A., Little, P. S., Feder, G. S., et al. (2014) · Trials · doi:10.1186/1745-6215-15-160 · Cited by 34
Medeiros-Domingo, M., Velásquez-Jones, L., Hernández, A. M., Ramón‐García, G., Valverde‐Rosas, S., Fuentes, Y., Vargas, A., Patiño, M., Pérez‐Villalva, R., Ortega-Trejo, J. A., et al. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05300516 · Cited by 34
Self-citationMontes‐Cobos, E., Schweingruber, N., Li, X., Fischer, H. J., Reichardt, H. M., & Lühder, F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01319 · Cited by 33
Anti-inflammatory Effect of Spironolactone on Human Peripheral Blood Mononuclear Cells
Miura, R., Nakamura, K., Miura, D., Miura, A., Hisamatsu, K., Kajiya, M., Nagase, S., Morita, H., KUSANO, K. F., Ohe, T., et al. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.sc0060049 · Cited by 31
Zhou, G., Johansson, U., Peng, X. R., Bamberg, K., & Huang, Y. (2016) · PubMed Central · Cited by 31
Asai, M., Monkawa, T., Marumo, T., et al. (2004) · Hypertension Research · doi:10.1291/hypres.27.971 · Cited by 28
Nielsen, F. T., Jensen, B. L., Hansen, P., Marcussen, N., & Bie, P. (2013) · BMC Nephrology · doi:10.1186/1471-2369-14-42 · Cited by 28
ÖZAÇMAK, H. S., ÖZAÇMAK, V. H., Barut, F., Araslı, M., & Uçan, B. H. (2014) · Journal of Surgical Research · doi:10.1016/j.jss.2014.04.040 · Cited by 28
Bánki, N. F., Vér, Á., Wagner, L. J., Vannay, Á., Degrell, P., Prókai, Á., Gellai, R., Lénárt, L., Szakál, D. N., Kenesei, É., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039938 · Cited by 25
Bertocchio, J., Barbe, C., Lavaud, S., Toupance, O., Nazeyrollas, P., Jaisser, F., & Rieu, P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153635 · Cited by 25
Self-citationNg, K. P., Jain, P., Gill, P. S., Heer, G., Townend, J., Freemantle, N., Greenfield, S., McManus, R. J., & Ferro, C. J. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010519 · Cited by 25
Taye, A., & Morawietz, H. (2011) · Europe PMC (PubMed Central) · Cited by 24
Myeloid Mineralocorticoid Receptor During Experimental Ischemic Stroke: Effects of Model and Sex
Frieler, R. A., Ray, J. J., Meng, H., Ramnarayanan, S. P., Usher, M. G., Su, E. J., Berger, S., Pinsky, D. J., Lawrence, D. A., Wang, M. M., et al. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.002584 · Cited by 23
Güllülü, M., Akdağ, İ., Kahvecioğlu, S., et al. (2006) · Renal Failure · doi:10.1080/08860220600779033 · Cited by 23
Zitt, E., Eller, K., Huber, J., Kirsch, A. H., Tagwerker, A., Mayer, G. J., & Rosenkranz, A. R. (2011) · PubMed Central · Cited by 22
Cooper, L. B., Hammill, B. G., Peterson, E. D., Pitt, B., Maciejewski, M. L., Curtis, L. H., & Hernandez, A. F. (2017) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.116.002946 · Cited by 22
Ma, F. Y., Han, Y., Nikolic‐Paterson, D. J., Kolkhof, P., & Tesch, G. H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145666 · Cited by 18
Wang, C., Wang, Z., Liang, L.-J., Wang, X., Ma, X., Liu, B., He, J., Shimosawa, T., & Xu, Q. (2017) · The Nephron journals/Nephron journals · doi:10.1159/000473702 · Cited by 18
Girerd, S., Frimat, L., Ducloux, D., Meur, Y. L., Mariat, C., Moulin, B., Mousson, C., Rieu, P., Dali‐Youcef, N., Mercklé, L., et al. (2018) · Trials · doi:10.1186/s13063-018-2956-1 · Cited by 15
Self-citationA Novel Aldosterone Antagonist Limits Renal Injury in 5/6 Nephrectomy
Fujihara, C. K., Kowala, M. C., Breyer, M. D., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-08383-2 · Cited by 13
Takata, H., Takeda, Y., Zhu, A., Cheng, Y., Yoneda, T., Demura, M., Yagi, K., Karashima, S., & Yamagishi, M. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01499.x · Cited by 12
Lahmer, T., Hermans, R. J. J., Schmaderer, C., Chang, J., Stock, K. F., Lutz, J., Heemann, U. W., & Baumann, M. (2012) · Kidney & Blood Pressure Research · doi:10.1159/000339649 · Cited by 12
Ng, K. P., Jain, P., Heer, G., Redman, V., Chagoury, O. L., Dowswell, G., Greenfield, S., Freemantle, N., Townend, J., Gill, P. S., et al. (2014) · Trials · doi:10.1186/1745-6215-15-158 · Cited by 12
Löfman, I. H., Szummer, K. E., Olsson, H., Carrero, J. J., Lund, L. H., & Jernberg, T. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009359 · Cited by 8
Cited by
Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes
Bakris, G. L., Agarwal, R., Anker, S. D., Pitt, B., Ruilope, L. M., Rossing, P., Kolkhof, P., Nowack, C., Schloemer, P., Joseph, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2025845 · Cited by 2,935
Cardiovascular events with finerenone in kidney disease and type 2 diabetes
Pitt, B., Filippatos, G., Agarwal, R., Anker, S. D., Bakris, G. L., Rossing, P., Joseph, A., Kolkhof, P., Nowack, C., Schloemer, P., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2110956 · Cited by 1,814
Molecular mechanisms and therapeutic targets for diabetic kidney disease
Tuttle, K. R., Agarwal, R., Alpers, C. E., Bakris, G. L., Brosius, F. C., Kolkhof, P., & Uribarri, J. (2022) · Kidney International · doi:10.1016/j.kint.2022.05.012 · Cited by 668
Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine
Agarwal, R., Kolkhof, P., Bakris, G., Bauersachs, J., Haller, H., Wada, T., & Zannad, F. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa736 · Cited by 638
Signaling pathways of chronic kidney diseases, implications for therapeutics
Yuan, Q., Tang, B., & Zhang, C. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01036-5 · Cited by 453
Metadata
- Authors
- Barrera-Chimal, J., Girerd, S., & Jaisser, F.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2019-08
- Volume
- 96
- Issue
- 2
- Pages
- 302-319
- ISSN
- 0085-2538 (ISSN-L)
- OpenAlex
- W2921544138
- Cited by
- 261
- References
- 176
- FWCI
- 20.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.